低危头颈部Merkel细胞癌术后放疗可降低局部复发风险
该回顾性分析纳入46例低危头颈部Merkel细胞癌患者,比较术后放疗与未放疗的局部复发风险。结果显示未放疗组局部复发率显著高于放疗组(26% vs. 0%,P = .02),但两组疾病特异性生存和总生存无差异,所有局部失败均有效挽救。
要点
- 低危头颈部MCC省略PORT与局部复发风险显著升高相关(26% vs. 0%,P = .02)。
- 两组MCC特异性生存和总生存无差异,局部失败均可有效挽救。
- 需结合副作用谱个案权衡PORT获益。
核心结论
- 在低危头颈部Merkel细胞癌患者中,省略术后放疗与局部复发风险显著升高相关。
- 术后放疗组与未放疗组的MCC特异性生存和总生存无差异。
研究设计与样本
- 回顾性分析2006至2015年治疗的46例低危头颈部Merkel细胞癌病例。
- 纳入标准为原发肿瘤≤2 cm、病理切缘阴性、前哨淋巴结活检阴性且无免疫抑制。
- 46例患者中23例接受术后放疗,23例未接受,无患者接受辅助化疗。
主要发现
- 未接受术后放疗的23例患者中6例发生局部复发。
- 未放疗组局部复发风险显著高于放疗组(26% vs. 0%,P = .02)。
- 所有患者中位随访3.7年,局部复发中位时间11个月。
- 所有局部失败均得到有效挽救。
- 两组在切缘、肿瘤大小、深度、淋巴血管侵犯状态或人口学特征上无显著差异。
关键数值与推荐
- 局部复发定义为原手术床2 cm内肿瘤复发。
临床怎么用
- 对于低危头颈部Merkel细胞癌,应个案权衡术后放疗的获益与副作用谱。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Merkel cell carcinoma (MCC) is a rare and often aggressive skin cancer. Typically, surgery is the primary treatment. Postoperative radiation therapy (PORT) is often recommended to improve local control. It is unclear whether PORT is indicated in patients with favorable Stage IA head and neck (HN) MCC. METHODS AND MATERIALS: We conducted a retrospective analysis of 46 low-risk HN MCC cases treated between 2006 and 2015. Inclusion criteria were defined as a primary tumor size of ≤ 2 cm, negative pathological margins, negative sentinel lymph node biopsy, and no immunosuppression. Local recurrence (LR) was defined as tumor recurrence within 2 cm of the primary surgical bed and estimated with the Kaplan-Meier method. RESULTS: Omission of PORT was offered to all 46 patients, of which 23 patients received PORT and 23 did not. No patient received adjuvant chemotherapy. There were no significant differences in surgical margins, tumor size, depth, lympho-vascular invasion status, or demographics between the two patient groups. Median follow-up for all patients was 3.7 years. Six of the 23 patients who did not receive PORT developed an LR. Compared to the group that received PORT, there was a significantly higher risk of LR in the group treated without PORT (26% vs. 0%, P = .02). Median time to LR was 11 months. All local failures were effectively salvaged. There was no difference in MCC-specific and overall survival between the 2 groups. CONCLUSIONS: For patients with HN MCC, omission of PORT was associated with a significantly higher risk of local recurrence even among those patients with the lowest-risk tumors (i.e., Stage IA without immune suppression). Thus, it is important to weigh the benefits of PORT against the side effect profile on a case-specific basis for each patient.
引用
- Takagishi SR, Marx TE, Lewis C, et al. Postoperative radiation therapy is associated with a reduced risk of local recurrence among low risk Merkel cell carcinomas of the head and neck. Adv Radiat Oncol. 2016. PMID: 28740894. doi:10.1016/j.adro.2016.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。